The report, in fact, indicates that the practice of corporate hospitals making huge margins from inpatients is widely prevalent.CCI was looking into a complaint filed by a patient's attendant, Vijay Sharma. BD Ltd's submissions during the investigation admitted that this was "standard industry practice followed by all manufacturing companies in India". The report noted that instead of charging "a reasonable margin" on the actual price at which the hospital procured the syringes, Max group was charging at MRP. It further submitted that it sold syringes at different discounts to hospitals depending on their size, volume purchased and as a strategy to bag a contract. The investigation also fixed individual responsibility within Max Hospital.

Source: Times of India December 06, 2017 19:49 UTC